Internal Medicine, Cardiovascular Disease · Cleveland, OH
NPI
1568812519
Since 2016
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
9500 Euclid Ave
Cleveland, OH, 44195
Phone (216) 444-2200
Groups this clinician bills Medicare through
Medicare paid, 2024
$92K
2,327 services
Medicare patients, 2024
1,006
Average age 73
Drug cost, 2024
$1.9M
1,196 prescriptions
Company payments, 2025
$23K
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bo Xu was code 93306 (echocardiography (tte/tee)), 410 times for 409 patients. In total Bo Xu billed 2,327 services in 40 codes, and Medicare paid $92K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93306 Echocardiography (TTE/TEE) | Facility | 410 | 409 | $49.29 | $20K |
| 93321 Echocardiography (TTE/TEE) | Facility | 208 | 197 | $5.31 | $1,104 |
| 93356 Echocardiography (TTE/TEE) | Facility | 206 | 206 | $8.56 | $1,764 |
| 93325 Echocardiography (TTE/TEE) | Facility | 182 | 174 | $2.27 | $413 |
| 93308 Echocardiography (TTE/TEE) | Facility | 169 | 160 | $18.32 | $3,095 |
| 99233 Hospital E&M - Subsequent | Facility | 138 | 34 | $89.83 | $12K |
| 99215 Office E&M - Established | Facility | 123 | 103 | $94.59 | $12K |
| 71275 CT/CTA - Chest | Facility | 84 | 83 | $58.35 | $4,902 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 74 | 67 | $12.49 | $924 |
| 99205 Office E&M - New | Facility | 63 | 63 | $130.60 | $8,228 |
| 99214 Office E&M - Established | Facility | 57 | 46 | $64.43 | $3,672 |
| 74174 CT/CTA - Abdomen and Pelvis | Facility | 46 | 45 | $69.70 | $3,206 |
| 93312 Echocardiography (TTE/TEE) | Facility | 43 | 43 | $76.43 | $3,287 |
| 93319 Echocardiography (TTE/TEE) | Facility | 41 | 41 | $16.97 | $696 |
| 99152 Anesthesia | Facility | 38 | 38 | $8.95 | $340 |
By year: 2022 $90K for 2,047 services; 2023 $94K for 2,266 services; 2024 $92K for 2,327 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bo Xu prescribed most often to Medicare patients was Camzyos (Mavacamten), with 206 prescriptions and refills. In total Bo Xu wrote 1,196 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Camzyos Mavacamten | 206 | 206 | 24 | $1.6M |
| Metoprolol Succinate Generic | 161 | 463 | 55 | $2,879 |
| Atorvastatin Calcium Generic | 136 | 382 | 45 | $1,360 |
| Eliquis Apixaban | 110 | 215 | 29 | $123K |
| Losartan Potassium Generic | 61 | 185 | 21 | $489 |
| Amlodipine Besylate Generic | 49 | 147 | 17 | $175 |
| Entresto Sacubitril/Valsartan | 44 | 91 | 11 | $53K |
| Jardiance Empagliflozin | 42 | 96 | 14 | $53K |
| Furosemide Generic | 35 | 94 | 13 | $109 |
| Farxiga Dapagliflozin Propanediol | 29 | 65 | Under 11 | $36K |
| Lisinopril Generic | 27 | 81 | Under 11 | $171 |
| Spironolactone Generic | 24 | 72 | Under 11 | $211 |
| Rosuvastatin Calcium Generic | 21 | 63 | Under 11 | $510 |
| Hydrochlorothiazide Generic | 18 | 54 | Under 11 | $46.18 |
| Carvedilol Generic | 18 | 50 | Under 11 | $94.45 |
Brand drugs: 451 claims; generic drugs: 745 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bo Xu $23K ($23K in general payments such as food, travel and fees) from 1 company. The largest payer was E.R. Squibb & Sons, L.L.C. with $23K.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 14 | $23K |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.